Shanghai ERP Biotechnology (revision 52)

Shanghai ERP Biotechnology Co., Ltd. (trading as ERP; erpbiotechnology.com) is a research-compound supplier trading as ERP from Shanghai, China, incorporated in 2018, supplying research peptides, SARMs and raw materials with batch documentation and tracked shipping.^[1][2]

The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in 2018 in Shanghai, the organisation is one of six covered here registered in that city.^[1] Its short designation coincides with a widely used business-software acronym, which has no bearing on the entity but does make it unusually difficult to research: a search for the trading name returns overwhelmingly unrelated results. The article records that as a practical observation for readers attempting verification.

The documentary base is the registry record, the organisation's own material and purchaser reports.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe conventional practice: lyophilised material in crimped vials, batch certificate with purity and appearance, insulated packaging on the incretin lines.^[5] Water figures have appeared on a minority of the submitted certificates.^[6]

Self-published capability claims are not corroborated here.^[2]

The catalogue follows the sector pattern closely, and no listing distinguishes the organisation from its comparators.^[2]

Submitted reports on ERP material to July 2026 are concentrated on the incretin range. Reported area percent figures have clustered in the high nineties, consistent with accompanying certificates where available.^[5]

The set includes two reports in which the purchaser also had the material assayed for endotoxin, both returning results below the reporting limit of the method used. Endotoxin is not a stability property and does not decrease on storage; a below-limit result on one vial is a fact about that vial.^[5][7] Endotoxin testing is rare in submissions to this wiki and is recorded where it occurs.

The PeptidePedia tally records 812 self-reported submissions to July 2026. Recurring positive themes are delivery reliability and responsiveness; recurring complaints concern certificate depth and the difficulty of researching the organisation at all.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a mean of self-reported submissions to PeptidePedia. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[8] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[7] Neither assessment is available here for this organisation or for any other covered on this wiki.

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.